{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:44:09Z","timestamp":1780710249441,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:00:00Z","timestamp":1759017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jphs.2025.09.010","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:20:02Z","timestamp":1759299602000},"page":"279-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Class effects of proton pump inhibitors in preventing oxaliplatin-induced peripheral neurotoxicity"],"prefix":"10.1016","volume":"159","author":[{"given":"Yusuke","family":"Mori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Mine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7708-2855","authenticated-orcid":false,"given":"Takehiro","family":"Kawashiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Koura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akito","family":"Tsuruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Koyanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"28","key":"10.1016\/j.jphs.2025.09.010_bib1","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J Clin Oncol"},{"issue":"11-12","key":"10.1016\/j.jphs.2025.09.010_bib2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1159\/000506232","article-title":"Comparison of antioxidant effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole","volume":"105","author":"Abed","year":"2020","journal-title":"Pharmacology"},{"key":"10.1016\/j.jphs.2025.09.010_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.freeradbiomed.2013.03.019","article-title":"Oxaliplatin-induced oxidative stress in nervous system-derived cellular models: could it correlate with in vivo neuropathy?","volume":"61","author":"Di Cesare Mannelli","year":"2013","journal-title":"Free Radic Biol Med"},{"issue":"16","key":"10.1016\/j.jphs.2025.09.010_bib4","doi-asserted-by":"crossref","first-page":"8859","DOI":"10.3390\/ijms23168859","article-title":"Omeprazole suppresses oxaliplatin-induced peripheral neuropathy in a rodent model and clinical database","volume":"23","author":"Mine","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jphs.2025.09.010_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/toxsci\/kfn114","article-title":"Assessment of chemical effects on neurite outgrowth in PC12 cells using high content screening","volume":"105","author":"Radio","year":"2008","journal-title":"Toxicol Sci"},{"issue":"3","key":"10.1016\/j.jphs.2025.09.010_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/HYPERTENSIONAHA.116.08408","article-title":"Proton pump inhibitors decrease soluble fms-Like tyrosine Kinase-1 and soluble endoglin secretion, decrease hypertension, and rescue endothelial dysfunction","volume":"69","author":"Onda","year":"2017","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.jphs.2025.09.010_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ddr.22013","article-title":"Differential effects of proton pump inhibitors and vonoprazan on vascular endothelial growth factor expression in cancer cells","volume":"84","author":"Ando-Matsuoka","year":"2023","journal-title":"Drug Dev Res"},{"issue":"2","key":"10.1016\/j.jphs.2025.09.010_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/0250-474X.91582","article-title":"Influence of proton pump inhibitors on dexamethasone-induced gastric mucosal damage in rats","volume":"73","author":"Swamy","year":"2011","journal-title":"Indian J Pharmaceut Sci"},{"issue":"10","key":"10.1016\/j.jphs.2025.09.010_bib9","doi-asserted-by":"crossref","first-page":"7980","DOI":"10.1007\/s00464-023-10269-6","article-title":"Long-term potassium-competitive acid blockers administration causes microbiota changes in rats","volume":"37","author":"Najah","year":"2023","journal-title":"Surg Endosc"},{"key":"10.1016\/j.jphs.2025.09.010_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120939","article-title":"Irbesartan reprofiling for the amelioration of ethanol-induced gastric mucosal injury in rats: role of inflammation, apoptosis, and autophagy","volume":"308","author":"Arab","year":"2022","journal-title":"Life Sci"},{"issue":"10","key":"10.1016\/j.jphs.2025.09.010_bib11","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s11010-023-04662-x","article-title":"Lansoprazole attenuates cyclophosphamide-induced cardiopulmonary injury by modulating redox-sensitive pathways and inflammation","volume":"478","author":"Hassanein","year":"2023","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"10.1016\/j.jphs.2025.09.010_bib12","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.bbrc.2006.04.170","article-title":"Beyond gastric acid reduction: proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells","volume":"345","author":"Becker","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jphs.2025.09.010_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/srep30007","article-title":"In vivo and in vitro protective effects of omeprazole against neuropathic pain","volume":"6","author":"Chanchal","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jphs.2025.09.010_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116055","article-title":"Identification of novel and potential PPAR\u03b3 stimulators as repurposed drugs for MCAO associated brain degeneration","volume":"446","author":"Usman","year":"2022","journal-title":"Toxicol Appl Pharmacol"},{"issue":"9","key":"10.1016\/j.jphs.2025.09.010_bib15","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/aps.2013.59","article-title":"Quercetin protects rat dorsal root ganglion neurons against high glucose-induced injury in vitro through Nrf-2\/HO-1 activation and NF-\u03baB inhibition","volume":"34","author":"Shi","year":"2013","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jphs.2025.09.010_bib16","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.2147\/DDDT.S193641","article-title":"Esomeprazole alleviates the damage to stress ulcer in rats through not only its antisecretory effect but its antioxidant effect by inactivating the p38 MAPK and NF-\u03baB signaling pathways","volume":"13","author":"Xie","year":"2019","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.jphs.2025.09.010_bib17","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.biopha.2017.11.028","article-title":"Esomeprazole ameliorates CCl4 induced liver fibrosis in rats via modulating oxidative stress, inflammatory, fibrogenic and apoptotic markers","volume":"97","author":"Eltahir","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"10.1016\/j.jphs.2025.09.010_bib18","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1007\/s10620-011-1607-0","article-title":"Mitochondrial dependent apoptosis: ameliorative effect of flunarizine on ischemia-reperfusion of celiac artery-induced gastric lesions in the rat","volume":"56","author":"Muthuraman","year":"2011","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.jphs.2025.09.010_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00210-008-0314-7","article-title":"Effects of esomeprazole on glutathione levels and mitochondrial oxidative phosphorylation in the gastric mucosa of rats treated with indomethacin","volume":"378","author":"Pastoris","year":"2008","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.jphs.2025.09.010_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3164\/jcbn.10-133","article-title":"Lansoprazole inhibits mitochondrial superoxide production and cellular lipid peroxidation induced by indomethacin in RGM1 cells","volume":"49","author":"Rai","year":"2011","journal-title":"J Clin Biochem Nutr"},{"key":"10.1016\/j.jphs.2025.09.010_bib21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cbi.2018.11.008","article-title":"Omeprazole protects against cisplatin-induced nephrotoxicity by alleviating oxidative stress, inflammation, and transporter-mediated cisplatin accumulation in rats and HK-2 cells","volume":"297","author":"Gao","year":"2019","journal-title":"Chem Biol Interact"},{"issue":"12","key":"10.1016\/j.jphs.2025.09.010_bib22","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.21873\/anticanres.16764","article-title":"Wakai eet al. Proton pump inhibitors ameliorate oxaliplatin-induced peripheral neuropathy: retrospective analysis of two real-world clinical databases","volume":"43","author":"Kobayashi","year":"2023","journal-title":"Anticancer Res"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861325000969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861325000969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T06:20:29Z","timestamp":1763446829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861325000969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1347861325000969"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2025.09.010","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Class effects of proton pump inhibitors in preventing oxaliplatin-induced peripheral neurotoxicity","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2025.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}